| 
 
 Invited 
            Speaker 
 Bee Products as Anti-infective Agents
 Laid Boukraa, Siti Amrah Sulaiman and Mokhtar Benhanifia
 Malaysia
 
 Honey and other bee products were subjected to laboratory and clinical 
            investigations during the past few decades and the most remarkable 
            discovery was their antibacterial activity. Honey has been used since 
            ancient times for the treatment of some diseases and for the healing 
            of wounds but its use as an anti-infective agent was superseded by 
            modern dressings and antibiotic therapy. Honey, propolis, royal jelly 
            and bee venom have a strong antibacterial activity. Even antibiotic-resistant 
            strains such as epidemic strains of methicillin resistant Staphylococcus 
            aureus (MRSA) and Vancomycine resistant Enterococcus 
            (VRE) have been found to be as sensitive to honey as the antibiotic-sensitive 
            strains of the same species. Propolis has attracted increased interest 
            in recent years due to its antimicrobial activity against a wide range 
            of pathogenic micro-organisms. Given the exceptional biological properties 
            attributed to it, royal jelly has considerable commercial appeal and 
            is today utilised in many sectors, ranging from the pharmaceutical 
            and food industries to the cosmetic and manufacturing sectors. Recent 
            studies have shown that bee venom also exhibits antibacterial activity. 
            Sensitivity of bacteria to bee products varies considerably within 
            the product and the varieties of the same product. Botanical origin 
            plays a major role in its antibacterial activity. The rapid emergence 
            of antibiotic resistant pathogens poses increasingly serious health 
            concerns worldwide. Approximately 70% of bacteria that cause infections 
            in hospitals are resistant to at least one of the antibiotics most 
            commonly used to treat infections. This antibiotic resistance is driving 
            up health care costs, increasing the severity of the disease, and 
            the fatality of certain infections. This emergence of antibiotic resistant 
            strains of pathogenic bacteria has confounded the current use of anti-infective 
            therapy, leading to the re-examination of earlier remedies such as 
            honey, royal jelly, propolis and bee venom.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 |